Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks
Status:
Suspended
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
National clinical trials, phase III, randomized, open, parallel, study of superiority, in
which three hundred thirty-six (336) participants of both sexes, aged between 18 and 65 years
will be randomly allocated to one of two treatment groups. The Group 01 will use Cefalium®
and group 02 will use Tylenol®.